Zolgensma Gene Therapy for SMA
Summary: Zolgensma, a costly gene therapy for Spinal Muscular Atrophy (SMA), offers hope to affected families in India by replacing the defective SMN1 gene to…
Summary: Zolgensma, a costly gene therapy for Spinal Muscular Atrophy (SMA), offers hope to affected families in India by replacing the defective SMN1 gene to…
Summary: Wave Life Sciences has pioneered RNA editing in clinical trials, marking a significant step in genetic disorder treatments. RNA editing corrects mRNA errors, restoring…
Premium Content! You need General Studies (GS) subscription to access this content. Join now to unlock premium content. JOIN NOW
Premium Content! You need General Studies (GS) subscription to access this content. Join now to unlock premium content. JOIN NOW
Premium Content! You need General Studies (GS) subscription to access this content. Join now to unlock premium content. JOIN NOW
Premium Content! You need General Studies (GS) subscription to access this content. Join now to unlock premium content. JOIN NOW
Premium Content! You need General Studies (GS) subscription to access this content. Join now to unlock premium content. JOIN NOW
Researchers have developed a miniature CRISPR tool, TnpB, for plant genome editing, addressing the challenges posed by the large size of traditional CRISPR proteins like…
New Zealand is proposing new legislation to modernize its gene technology laws, aiming to make it easier to develop and use gene technologies like gene…
Please confirm you want to block this member.
You will no longer be able to:
Please allow a few minutes for this process to complete.